Conavi Medical Unveils Next-Gen Dual-Modality Catheter for Cardiac Interventions
06/12/2024
0:00
5:49
Conavi Medical CEO Tom Looby joined Steve Darling from Proactive to share updates about the company’s innovative dual-modality catheter, developed at Sunnybrook Hospital in Toronto, which combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to improve visualization during coronary interventions. These procedures are among the most frequently performed worldwide.
Looby highlighted the Novasight 3.0 system, which features enhanced imaging, AI-driven guidance to help doctors recognize tissue and size lumens, and a user-friendly design for seamless clinical integration. With regulatory approvals from the FDA and Health Canada, Conavi plans to commercialize the product within the next one to two years.
Medical professionals have responded positively to the dual-modality approach, which builds on prior innovations while providing a best-in-class solution for guiding complex cardiac procedures. This next-generation technology has the potential to significantly improve outcomes in coronary interventions globally.
#proactiveinvestors #conavimedicalcorp #titanmedical #tsxv #cnvi
#CardiovascularTechnology #MedicalInnovation #AIHealthcare #IntravascularUltrasound #OpticalCoherenceTomography #Novasight3 #FDAApproval #CardiacCare #HealthcareTech#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
D'autres épisodes de "Proactive - Interviews for investors"
Ne ratez aucun épisode de “Proactive - Interviews for investors” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.